1. The role of egl-47 in the chloride transporter phenotypes is a bit unclear. The fact that egl-47(dm) mutations stimulate egg-laying in Cl-transporter mutant backgrounds but inhibit in wild-type backgrounds implies that egl-47(dm) activates a chloride conductance in the HSNs. Is there any evidence this is true? As far as I know EGL-47 is not thought to be a GABA receptor.
2. In figure 6, unc-49 mutations are less hypercontracted than abts-1; kcc-2 double mutants, presumably because the former removes GABA inhibition while the latter converts inhibition to excitation. This would predict that an unc-49; abts-1; kcc-2 triple would look like the unc-49 single. This (or a similar experiment with e.g. unc-25) would be a nice control to include.
Referee #2 (Remarks to the Author):
This is an interesting paper on the roles of two distinct chloride transporters (ABTS-1, an Na-driven Cl-HCO3 exchanger; and KCC-2, a K-Cl cotransporter) in ionotropic GABAergic effects in C. elegans. Using genetic and behavioral techniques, the authors show that while loss of one of these ion transporters leads to minor behavioral defects, animals lacking both Cl extruders are paralyzed. The results provide substantial evidence for the conclusion that ABTS-1 acts as a significant Cl extruder promoting the inhibitory action of GABAa receptors. While the conclusions regarding the hyperpolarizing vs. depolarizing actions of GABA are based on indirect (behavioral) evidence, the data as a whole are consistent with the main conclusions. I don't have any major concerns, but the following points should be addressed in a revised version of this paper.
Major comments 1) Why is the K-Cl cotransporter termed "KCC-2"? In all mammalian species studied so far, KCC2 is expressed in central neurons only. Moreover, the dendrogram in Tanis et al (2009) does not really support this nomenclature. Please see also KCC nomenclature for Drosophila. 2) What is the level of CO2/HCO3 in the tissues of C. elegans under the present experimental conditions? It seems that the experiments have been carried out in the nominal absence of CO2/HCO3, and hence the HCO3 levels might be less than 0.5 mM. Is this enough for effective Cl transport by the well-studied mammalian homologs of ABTS-1? (In the oocyte experiments, 1.5 % CO2 has been used, but this is probably much higher than the level in the worms.) An interesting question here is whether the C. elegans muscle cells express carbonic anhydrase -this would be easy to find out. 3) Would it not be possible to make direct intracellular recordings of GABA actions in the muscle cells? The authors should briefly explain why a purely behavioral approach was chosen in order to elucidate the actions of GABA. 4) Why is there a permanent contraction in the double mutant? Is this because GABAa receptors are tonically activated also in the absence of exogenous muscimol? If yes, then applying picrotoxin should lead to a relaxation/lengthening in the double mutant (bicuculline is ineffective on many types of invertebrate GABAaRs, while picrotoxin has a broader spectrum of action). The authors state that "Na-driven Cl-HCO3 can extrude Cl and *could* contribute to the cellular Cl gradient". A key question here is whether this is a significant contribution for GABAaRmediated inhibition, hence the sentence should read "... and could significantly contribute to the cellular Cl gradient and to hyperpolarizing GABA actions ..." -p. 21 (above topic): The authors note that NDCBE is expressed in mammalian neurons (Grichtchenko et al., Chen et al). This should be added to the Introduction. -The terms UNC-49 and GABAaRs: I would suggest using GABAaR (wherever possible) after the definition that is provided on p. 4. Now these two terms are used interchangeably throughout the paper.
-pp. 4-5: For a non-specialist reader, the two sentences regarding egg-laying behavior would need some clarification. -p. 22: Luckermann et al were certainly not those who first demonstrated intracellular acidification caused by efflux of HCO3 across GABAaRs. As is evident also from the L¸ckermann paper's references, this was done by Voipio and Kaila in 1987 in crayfish muscle fibres and later on by the same team in mammalian neurons (Pasternack et al., 1993; see Kaila 1994 for review). -p. 22: "Acidification of the brain induced by CO2 inhalation has long been used clinically to terminate seizure activity". This is not true (see Tolner et al., Epilepsia 2010) and the sentence should be removed or rewritten. Furthermore, there are numerous *intrinsic* acid-base mechanisms that are likely to contribute to seizure termination, which include the activation of glial Nadependent HCO3 uptake (see e.g. Ransom Prog Brain Res. 2000;125:217-28) and also, as suggested by the authors, NDAE.
-Recent work has shown that KCC2 has structural roles in mammalian neurons. The present data (including the unidirectional compensation at the level of transcription) suggest that the phenotype of the double mutant is not based on a structural deficit. The authors might add a brief note on this topic. -p. 19: "These results imply that a principle physiological function of NDAEs is to control the cellular Cl-gradient and that any analysis of Cl-extrusion from excitable cells needs to take into account this type of transporter." Excitable cells express a large variety of Cl transporters, and so far there is not a single cell type where the "chloride budget" can be derived from a quantitative analysis of membrane transporters. Hence I suggest down-toning this sentence (especially "any analysis"). Bellemer and co-authors describe the roles of an anion exchanger, abts-1, and its genetic interactions with kcc-2, another anion transporter, and unc-49, a GABA receptor, in C. elegans. These anion regulators are of growing interests in neural plasticity and behavior because through effects on the Cl gradient they modulate membrane potential and hence excitability of cells. Early publications from this lab established a fruitful genetic screen using a egg laying defective mutant, egl-47(dm) to isolate genetic suppressor mutations that stimulate egg laying, which led them to identify kcc-2 (published in Tanis 2009), and here, abts-1, an SLC4 transporter protein. Loss of function in abts-1 causes similar effects as kcc-2 mutants. In an oocyte expression system, abts-1 shows dependency on Na, and appears to transport iodide. In C. elegans, they focused on two GABA mediated behaviors, body muscle relaxation and egg laying. The behavior quantification in genetic single or double mutants led them to conclude that without abts-1 (or kcc-2), activation of the GABA receptor unc-49 leads to excitation, not inhibition. The effects of abts-1 are due to cell autonomous action of abts-1, similar to kcc-2. abts-1 kcc-2 double mutants exhibit severer defects than each single mutant, supporting they have redundant functions. A general consensus is that the effect on Cl gradient is developmentally regulated and correlated with neuronal maturation. Using a transcriptional reporter they find that abts-1 shows a temporal regulation during the development of the egg laying neuron HSN, similar to their observation with kcc-2.
Overall, their findings reveal in vivo functional requirements for Cl ion regulators in GABA mediated neurotransmission. The analyses in C. elegans are quantitative and thorough, establishing a valuable platform for future studies. However, the oocyte expression experiments are presented in poor clarity, and many details and data are omitted, making it difficult to evaluate the conclusions. Should the authors amend the concerns, the manuscript is in principle suited for publication in EMBO.
1. pg 8 and fig. 2 : the description of the experiments is not clear to an audience outside of the field. e.g. the text states: "the ion transport activity by abts-1 is somewhat lower than that of many other HCO3 transporters (data not shown)." It is unclear which HCO3 transporters were compared with, based on which observations. The last statement of the same paragraph "monitoring of Vm indicated that this transport activity was electronneutral (data not shown)." As this manuscript is the first to provide the protein activity characterization, there is no way to evaluate the statement without showing the data. Similarly, the last sentence of this section on page 9: the authors state: "these data demonstrate that ABTS-1 can transport halides into the cell in a fashion similar to that observed when extracellular Na is removed". But this reviewer had difficulty to figure out which data led to this conclusion, as there is no similarities between Figure 2D and A. This section needs substantial revision to include the data and analysis in sufficient details for evaluation and and to make the text accessible to non experts. 2. It is unclear how the anion exchangers interact with egl-47 mutant protein. The authors should discuss this further. 3. Figure 6 : the abts-1 kcc-2 double mutants show much severer body size and bend defects than unc-49 alone. Can the authors discuss what might cause this difference? Do abts-1 and kcc-2 solely function in GABA mediate behaviors? 4. the authors should make it uniform whether to use egl-47(dm) or egl-47(gf) to refer the same mutation. 5. pg 4: last paragraph opening sentence missing words. Pg 11: an extra "or that". The text describing the cell autonomous requirement seems unnecessarily long and repetitive. 6. The title of supplemental table: "novel plasmids...", recommend to delete "novel", as they are standard plasmids. The reviewers mostly asked for clarifications regarding issues that were not fully/clearly explained in our original manuscript. We have revised the manuscript to give more detailed explanations of most of the issues raised by the reviewers, and in several cases have added additional data to supplemental figures that bear on these issues. We have had to keep the additions to the main text brief and also had to make corresponding cuts to keep the manuscript under the 55,000 character limit. Additionally, we have moved Panel B of Figure 4 to the Supplemental Information as Supplemental Figure S5 in order to create additional room in our main document. Below is an itemized list of every specific issue raised by a reviewer along with a detailed response, including a description of exactly how the manuscript has been altered to deal with the issue. In some cases we give a detailed explanation of an issue in this letter, but due to limited space did not add an explanation to the manuscript itself ñ we have indicated this explicitly in each of these cases.
Referee #1: We agree that the isolation of both abts-1 and kcc-2 from the egl-47(dm) suppressor screen and the striking synthetic phenotype observed in abts-1;egl-47(dm) and kcc-2;egl-47(dm) double mutants suggest a role for EGL-47 in activating a chloride conductance. There is no direct evidence for this role of EGL-47, and thus far, attempts to express EGL-47 in heterologous cells have not been fruitful. We have added a sentence to the first paragraph of the Discussion on page 18 stating that our results imply a role for EGL-47 in activating a chloride conductance.
2. In figure 6, We agree that the phenotype of the abts-1;unc-49;kcc-2 triple mutant would be expected to look like the unc-49 single mutant if the synthetic phenotype produced by combining abts-1 and kcc-2 were due solely to excitatory GABA signaling. We have constructed abts-1;unc-49;kcc-2 triple mutants and abts-1;unc-25;kcc-2 triple mutants (where unc-25 encodes the GABA biosynthetic enzyme, GAD) and found that these triple mutants indeed have modestly, but significantly improved body length as compared to abts-1;kcc-2 double mutants. The triple mutants also have improved motility. This result is consistent with our model of ABTS-1 and KCC-2 function. unc-49 and unc-25 do not fully suppress the abts-1;kcc-2 phenotype, suggesting that conductances from the many C. elegans chloride channels other than UNC-49 are also disturbed by the loss of ABTS-1 and KCC-2. We have included the body-length experiments described above as a new paragraph on page 15 of the Results, with the data shown in Supplemental Figure S7 .
Referee #2:
Why is the K-Cl cotransporter termed "KCC-2"? In all mammalian species studied so far, KCC2 is expressed in central neurons only. Moreover, the dendrogram in Tanis et al (2009) does not really support this nomenclature. Please see also KCC nomenclature for Drosophila.
We agree that C. elegans KCC-2 is not strictly orthologous to mammalian KCC2, and in fact no C. elegans KCC is obviously orthologous to any mammalian KCC. C. elegans gene nomenclature is such that gene families are assigned three-or four-letter names and then numbered sequentially. KCC-2 was named based on the fact that another KCC had previously been published under the name KCC-1. The C. elegans community uses a central gene nomenclature committee to approve all gene names and ensure that each gene is referred to by just one name. At this point, the committee has officially assigned names to all the C. elegans KCCs and we follow their ruling. Note also that the supplemental material in Tanis et al. (2009) briefly describes the expression patterns and mutant phenotypes of all C. elegans KCCs, and no other KCC appears to be more functionally analogous to mammalian KCC2 than is C. elegans KCC-2. For example, although KCC-2 is expressed in muscles and we focus on muscle expression in this manuscript, it is also the only C. elegans KCC widely expressed in neurons. We have not altered the manuscript to address this issue.
What is the level of CO2/HCO3 in the tissues of C. elegans under the present experimental conditions? It seems that the experiments have been carried out in the nominal absence of CO2/HCO3, and hence the HCO3 levels might be less than 0.5 mM. Is this enough for effective Cl transport by the well-studied mammalian homologs of ABTS-1? (In the oocyte experiments, 1.5 % CO2 has been used, but this is probably much higher than the level in the worms.) An interesting question here is whether the C. elegans muscle cells express carbonic anhydrasethis would be easy to find out.
We agree with the general concern that the CO2/HCO3-levels in C. elegans tissues are difficult to estimate during our behavioral experiments (they are carried out in animals grown in air presumably containing 0.03-0.04% C02). NDAEs from mammals and squid have been shown to absolutely require HCO3-for transport activity. Drosophila NDAE1, however, does function in the absence of HCO3- (Romero et al, 2000) . Like other animals, C. elegans expresses many carbonic anhydrases including one, CAH-4, that is expressed in C. elegans body wall muscles and could thus be a source of HCO3-for ABTS-1 (Hall et al, 2008 ). RNAi knockdown of CAH-4 has been shown to produce an uncoordinated locomotion phenotype, which would be consistent with a defect in GABAergic neurotransmission (Simmer et al, 2003) . We have added a brief discussion of this point to page 19 of our manuscript. 
Would it not be possible to make direct intracellular recordings of GABA actions in the muscle cells? The authors should briefly explain why a purely behavioral approach was chosen in order to elucidate the actions of GABA.
We added a sentence to page 11 of the Results with such an explanation, and elaborate on the explanation here. The standard technique to demonstrate a change in the chloride reversal potential in the body wall muscles of abts-1 and kcc-2 mutants would be the gramicidin-perforated patch technique, which would allow us to measure whole-cell GABA-activated currents without dialyzing intracellular chloride with the pipette solution. We performed fairly extensive experiments to determine the viability of this approach in collaboration with Dr. Zhao-Wen Wang, an expert at C. elegans body wall muscle patch clamp at the University of Connecticut Health Center. We found that we were unable to achieve satisfactory perforation with gramicidin (although control gramicidin perforation of mammalian cells worked well in our hands) and thus determined that a behavioral rather than electophysiological approach would be required. It is our understanding that several other laboratories have also failed to achieve gramicidin perforation of C. elegans muscle membranes. The poor ability of gramicidin to perforate C. elegans membranes may be due to the fact that C. elegans membranes differ in lipid composition from mammalian membrane, for example having little or no cholesterol. We note that we did successfully carry out recordings of miniature postsynaptic potentials and voltage-gated potassium currents in muscles of abts-1 mutants in wholecell patch mode and found, as expected, that the muscles showed grossly normal activity. Because the recording pipette solution dialyzes the normal intracellular solution in such experiments, however, the results do no bear on whether intracellular chloride levels are perturbed in abts-1 mutants to alter GABA signaling.
Why is there a permanent contraction in the double mutant? Is this because GABAa receptors are tonically activated also in the absence of exogenous muscimol? If yes, then applying picrotoxin should lead to a relaxation/lengthening in the double mutant (bicuculline is ineffective on many types of invertebrate GABAaRs, while picrotoxin has a broader spectrum of action).
Bicuculline is indeed ineffective on the UNC-49 GABA receptors (Bamber et al, 2003 ). We have not tested the action of picrotoxin on intact worms, but there is evidence that some UNC-49 heteromers are picrotoxin insensitive (Bamber et al, 2003) . As described in detail under item #2 for reviewer #1, we have done a genetic experiment (using a mutation to inactivate GABAa receptors rather than picrotoxin) that addresses this issue and have included the experiment at Supplemental Figure 6 . We agree that the effects of ABTS-1 on intracellular pH could play a role in its control of muscle contractility. However, loss of ABTS-1 function would be predicted to result in intracellular acidification, and intracellular acidification is generally associated with a loss of muscle contractility. This is the opposite of the abts-1 mutant phenotype. We have added a brief discussion of this point to page 19 of the Discussion section. We have changed our language as suggested.
-p. 21 (above topic): The authors note that NDCBE is expressed in mammalian neurons (Grichtchenko et al., Chen et al). This should be added to the Introduction.
We have added this information to our Introduction.
-The terms UNC-49 and GABAaRs: I would suggest using GABAaR (wherever possible) after the definition that is provided on p. 4. Now these two terms are used interchangeably throughout the paper.
We agree that using terms consistently is important for clarity. We cannot expunge the term UNC-49 entirely as we need to refer to mutations in the C. elegans gene using ìunc-49î as this is an iron rule of C. elegans genetic nomenclature (Hodgkin, 1995). Thus we have revised our paper to always use the term UNC-49 to refer to the C. elegans GABA receptor and to always use the term GABAaR to refer to mammalian GABA receptors (or GABA receptors in general). This will hopefully clarify exactly which receptor is being discussed. The reviewer brings up an interesting point. Although it is not necessary to hypothesize defects in synaptic structure to explain any of our results, we also believe our data do not rule out the possibility that the double mutant might have structural defects in some synapses ñ we simply have not examined this issue. Our previous publication (Tanis et al., 2009) did discuss the data on mammalian KCC2 affecting neural structure, and in that paper we extensively examined the structure of HSN neurons in the kcc-2 single mutant for defects. However, we found no structural defects. We would want to do a similar detailed analysis before making a statement about the possibility that ABTS-1 or a combination of KCC-2 and ABTS-1 might affect synaptic structure. As such an analysis cannot fit into the current manuscript, we would prefer not to raise the issue in the manuscript.
- We have toned down our language as suggested. We have made all of the changes suggested above.
